Julia Schaft | Managing Director

Julia Schaft, Managing Director, BioRN

After completing her PhD in molecular and developmental biology at the University of Giessen and the European Molecular Biology Laboratory in Heidelberg (Germany) in 2002, Julia continued her scientific research on the differentiation of human embryonic stem cells at Genea Ltd in Sydney Australia, an IVF clinic with a strong focus on research and innovation in the IVF and human stem cell field. Julia then took over leadership responsibilities in scientific project management and the supervision of all of Genea’s embryo research licences. In 2014 Julia relocated back to Germany and took on an administrative role at the European Molecular Biology Laboratory in Heidelberg (Germany) building up the philanthropic fundraising program, the Friends of EMBL. She joined BioRN in 2016 as a project manager for international R&D and translational initiatives in the life sciences sector, and was recently appointed Managing Director.


On-Floor Seminar: Thursday 16th May @ 13:50

BioRN initiatives in leveraging the unique combination of global pharma and leading academic institutions in the region

  • HAEP – a new instrument for facilitated technology transfer between SMEs, academia and global healthcare companies
  • Health Axis Europe critical mass: a large international network of innovators
  • The vibrant Rhine/Main/Neckar life science region
last published: 14/May/19 13:35 GMT

back to speakers

The World Advanced Therapies and Regenerative Medicine Congress and Exhibition is an international conference and exhibition featuring the latest in advanced therapies, bioengineering and surrounding technology. To attend the conference which features global leaders in the biopharma and regenerative medicine industries, there is a registration fee. The exhibition is free to visit.

Register your pass here.